Cipla is a large cap pharmaceutical company belonging to Nifty 50 group of companies. Cipla Share Price reflects the current financial status of the company.

Live Stock Quote: Unfortunately, we could not get stock quote NSE:CIPLA this time.

Cipla Share Price Graph




Cipla was incorporated in 1935 in the name of Chemical, Industrial & Pharmaceutical Laboratories by Khwaja Abdul Hamied. He had some proprietary formula for some drugs and medicines which he donated to the company without charging any royalty. Later, in the same year, the company was named Cipla and was registered as a limited company with a paid up capital of 6 lakhs rupees.

Currently Cipla is a major name in Indian drug market. It is a large-cap company belonging to Nifty 50 group. The company has strong global presence. 55% of its revenue comes from its business abroad. The company manufactures drugs for human and veterinary uses. It focuses on new formulations as well. Besides drugs it has also forayed into manufacture of bulk drug and pesticides. In addition it earns its revenue from business of food and beverages, oral hygiene products, personal care products, room fresheners and detergents.

Currently, Cipla has a presence in drug market of 170 countries. Its manufacturing units are approved by world regulatory bodies like USFDA, WHO – Canada, UK – MHRA.

Cipla runs two institutes in the name of  Cipla Cancer Palliative Care & Training Centre and Dr. K.A Hamied Institute.

Cipla has manufactured many pioneering drugs in India and abroad. Some of them are oral contraceptive pills in the name of i-Pill, CFC-free inhalers in US and Europe, generic version of drugs to treat H1N1 influenza for local market , Touch Breast Scan (TBS) for non-evasive early stage breast cancer detection – among many others. Through a recent deal of Rs 95 crores, Piramal Healthcare has bought the  intellectual property right of the drug i-Pill.

The company has received many awards for excellence in drug manufacturing field.

Company Financials – Cipla Share Price is Rs 534.75 (as on 19.06.17, 09.20 hrs.) in BSE. As per latest data, the standalone basis P/E is 44.32 versus average industry PE of 28.41, EPS is Rs 12.12. Market cap is Rs 43,209 crores. The face value of a share is Rs 2.

For more information on other companies, kindly visit the stock technicals page.